A carregar...
Efficacy and Safety of Insulin Glargine 300 U/mL Versus Insulin Glargine 100 U/mL in High-Risk and Low-Risk Patients with Type 2 Diabetes Stratified Using Common Clinical Performance Measures
Background: To determine whether previously reported reductions in hypoglycemia associated with insulin glargine 300 U/mL (Gla-300) compared with insulin glargine 100 U/mL (Gla-100) are impacted by patient risk category in type 2 diabetes (T2D), clinical performance measures based on the Healthcare...
Na minha lista:
| Publicado no: | Diabetes Technol Ther |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Mary Ann Liebert, Inc.
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5444481/ https://ncbi.nlm.nih.gov/pubmed/28467113 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/dia.2016.0454 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|